News | November 01, 2010

Boston Scientific to Sell Neurovascular Business

November 2, 2010 – Boston Scientific will sell its neurovascular business to Stryker for $1.5 billion in cash. Of that purchase price, $1.4 billion will be paid at closing, and the remaining $100 million will be paid upon commercialization of the Target Detachable Coils. Several manufacturing facilities will also be transferred to Stryker.

Boston Scientific’s neurovascular business develops less-invasive medical technologies used to treat brain aneurysms and other types pf cerebrovascular disease.

“We deeply appreciate the contributions of our neurovascular employees and wish them continued success going forward in this new venture,” said Ray Elliott, president and CEO of Boston Scientific. “We believe this transaction will prove to be a win-win for all parties.”

For more information: www.bostonscientific.com, www.stryker.com

Related Content

Mobile Stroke Unit Gets Patients Quicker Treatment Than Traditional Ambulance

Image courtesy of UTHealth McGovern Medical School

News | Stroke | August 16, 2019
Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells per minute....
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Stroke | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Stroke | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging, ...
Videos | Stroke | May 16, 2019
This is an example of a carotid artery reporting module from Change Healthcare at...
 UTHealth Research Finds Telemedicine Stroke Patients Receive Consistent Care 24/7
News | Stroke | April 24, 2019
Stroke patients examined remotely by a teleneurologist were treated as quickly and effectively after hours as during...
New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019
Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients...
Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research
News | Stroke | March 19, 2019
iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research...
Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System
News | Stroke | February 15, 2019
Corindus Vascular Robotics Inc. is seeking premarket clearance from the U.S. Food and Drug Administration (FDA) to use...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
Overlay Init